Dermatology NewsUpadacitinib earns FDA approval for ankylosing spondylitis May 2, 2022Psoriatic ArthritisAtopic Dermatitis
Dermatology NewsParents’ autoimmune diseases may affect children’s developmentMay 2, 2022PsoriasisPsoriatic Arthritis
Multimodal imaging of DIP-joint and SEC can help distinguish PsA from psoriasis or OAApril 27, 2022Psoriatic Arthritis
Dermatology NewsLong-term efficacy, safety data for ixekizumab in pediatric psoriasis reportedApril 25, 2022PsoriasisPsoriatic ArthritisPediatrics
Dermatology NewsSecukinumab’s antipsoriatic effects confirmed in U.S. patient populationApril 25, 2022Psoriatic ArthritisPsoriasis
Dermatology NewsHypocaloric diet controls joint activity in psoriatic arthritis – regardless of weight lossApril 14, 2022Psoriatic Arthritis
Dermatology NewsApremilast has neutral effect on vascular inflammation in psoriasis studyApril 8, 2022PsoriasisPsoriatic ArthritisMixed Topics
Dermatology NewsTrial gives new guidance for choosing initial PsA treatmentMarch 22, 2022Psoriatic Arthritis
Dermatology NewsStudy links air pollution to psoriasis flaresMarch 14, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsCV risk biomarkers tentatively identified in psoriatic diseaseMarch 11, 2022Psoriatic ArthritisPsoriasis
Dermatology NewsDrug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasisMarch 11, 2022Psoriatic ArthritisPsoriasis
Dermatology NewsMethotrexate plus leflunomide proves effective for PsAMarch 8, 2022Psoriatic Arthritis
Dermatology NewsOne-third of psoriatic arthritis patients could have metabolic syndrome, data analysis findsMarch 4, 2022Psoriatic ArthritisPsoriasisMixed Topics
An Update on JAK Inhibitors in Skin DiseaseMarch 3, 2022Atopic DermatitisPsoriasisPsoriatic Arthritis
Dermatology NewsGuselkumab controls axial involvement in PsA through 2 yearsFebruary 10, 2022Psoriatic Arthritis
